Skip to main content
Top
Published in: BMC Psychiatry 1/2019

Open Access 01-12-2019 | Somatoform Disorder | Study protocol

Study design of the Routine Outcome Monitoring for Geriatric Psychiatry & Science (ROM-GPS) project; a cohort study of older patients with affective disorders referred for specialised geriatric mental health care

Authors: Richard C. Oude Voshaar, Ton D. F. Dhondt, Mario Fluiter, Paul Naarding, Sanne Wassink, Maureen M. J. Smeets, Loeki P. R. M. Pelzers, Astrid Lugtenburg, Martine Veenstra, Radboud M. Marijnissen, Gert-Jan Hendriks, Lia A. Verlinde, Robert A. Schoevers, Rob H. S. van den Brink

Published in: BMC Psychiatry | Issue 1/2019

Login to get access

Abstract

Background

Affective disorders, encompassing depressive-, anxiety-, and somatic symptom disorders, are the most prevalent mental disorders in later life. Treatment protocols and guidelines largely rely on evidence from RCTs conducted in younger age samples and ignore comorbidity between these disorders. Moreover, studies in geriatric psychiatry are often limited to the “younger old” and rarely include the most frail. Therefore, the effectiveness of treatment in routine clinical care for older patients and impact of ageing characteristics is largely unknown.

Objective

The primary aim of the Routine Outcome Monitoring for Geriatric Psychiatry & Science (ROM-GPS) – project is to examine the impact of ageing characteristics on the effectiveness of treatment for affective disorders in specialised geriatric mental health care.

Methods

ROM-GPS is a two-stage, multicentre project. In stage one, all patients aged ≥60 years referred to participating outpatient clinics for specialised geriatric mental health care will be routinely screened with a semi-structured psychiatric interview, the Mini International Neuropsychiatric Interview and self-report symptom severity scales assessing depression, generalized anxiety, hypochondria, and alcohol use. Patients with a unipolar depressive, anxiety or somatic symptom disorder will be asked informed consent to participate in a second (research) stage to be extensively phenotyped at baseline and closely monitored during their first year of treatment with remission at one-year follow-up as the primary outcome parameter. In addition to a large test battery of potential confounders, specific attention is paid to cognitive functioning (including computerized tests with the Cogstate test battery as well as paper and pencil tests) and physical functioning (including multimorbidity, polypharmacy, and different frailty indicators). The study is designed as an ongoing project, enabling minor adaptations once a year (change of instruments).

Discussion

Although effectiveness studies using observational data can easily be biased, potential selection bias can be quantified and potentially corrected (e.g. by propensity scoring). Knowledge of age-related determinants of treatment effectiveness, may stimulate the development of new interventions. Moreover, studying late-life depressive, anxiety and somatic symptom disorders jointly enables data-driven studies for more optimal classification of these disorders in later life.

Trial registration

Dutch Trial Register: NL6704 (www.​trialregister.​nl). Retrospectively registered on 2017-12-05.
Literature
1.
go back to reference Beekman ATF, Bremmer MA, Deeg DJH, et al. Anxiety disorders in later life: a report from the longitudinal aging study Amsterdam. Int J Geriatr Psychiatry. 1998;13:717–26.CrossRef Beekman ATF, Bremmer MA, Deeg DJH, et al. Anxiety disorders in later life: a report from the longitudinal aging study Amsterdam. Int J Geriatr Psychiatry. 1998;13:717–26.CrossRef
2.
go back to reference Gum AM, King-Kallimanis B, Kohn R, Phil M. Prevalence of mood, anxiety, and substance-abuse disorders for older americans in the National Comorbidity Survey-Replication. Am J Geriatr Psychiatry. 2009;17:769–81.CrossRef Gum AM, King-Kallimanis B, Kohn R, Phil M. Prevalence of mood, anxiety, and substance-abuse disorders for older americans in the National Comorbidity Survey-Replication. Am J Geriatr Psychiatry. 2009;17:769–81.CrossRef
3.
go back to reference Luppa M, Sikorski C, Luck K, et al. Age and gender-specific prevalence of depression in latest-life – systematic review and meta-analysis. J Affect Disord. 2012;136:212–21.CrossRef Luppa M, Sikorski C, Luck K, et al. Age and gender-specific prevalence of depression in latest-life – systematic review and meta-analysis. J Affect Disord. 2012;136:212–21.CrossRef
4.
go back to reference Hilderink PH, Collard R, Rosmalen JGM, Oude Voshaar RC. Prevalence of somatoform disorders and medically unexplained symptoms in old age populations in comparison with younger age groups: a systematic review. Ageing Res Rev. 2013;12:151–6.CrossRef Hilderink PH, Collard R, Rosmalen JGM, Oude Voshaar RC. Prevalence of somatoform disorders and medically unexplained symptoms in old age populations in comparison with younger age groups: a systematic review. Ageing Res Rev. 2013;12:151–6.CrossRef
6.
go back to reference Hilderink PH, Collard R, Rosmalen GJ, Oude Voshaar RC. How does ageing affect the impact of medically unexplained symptoms and medically explained symptoms on health-related quality of life. Int J Geriatr Psychiatry. 2015;30:737–43.CrossRef Hilderink PH, Collard R, Rosmalen GJ, Oude Voshaar RC. How does ageing affect the impact of medically unexplained symptoms and medically explained symptoms on health-related quality of life. Int J Geriatr Psychiatry. 2015;30:737–43.CrossRef
7.
go back to reference Zivin K, Wharton T, Rostant O. The economic, public health, and caregiver burden of late-life depression. Psychiatr Clin North Am. 2013;36:631–49.CrossRef Zivin K, Wharton T, Rostant O. The economic, public health, and caregiver burden of late-life depression. Psychiatr Clin North Am. 2013;36:631–49.CrossRef
8.
go back to reference Löwe B, Spitzer RL, Williams JBW, Mussell M, Schellberg D, Kroenke K. Depression, anxiety and somatization in primary care: syndrome overlap and functional impairment. Gen Hosp Psychiatry. 2008;30:191–9.CrossRef Löwe B, Spitzer RL, Williams JBW, Mussell M, Schellberg D, Kroenke K. Depression, anxiety and somatization in primary care: syndrome overlap and functional impairment. Gen Hosp Psychiatry. 2008;30:191–9.CrossRef
9.
go back to reference Kohlmann S, Gierk B, Hilbert A, Brähler E, Löwe B. The overlap of somatic, anxious and depressive syndromes: a population-based analysis. J Psychosom Res. 2016;90:51–6.CrossRef Kohlmann S, Gierk B, Hilbert A, Brähler E, Löwe B. The overlap of somatic, anxious and depressive syndromes: a population-based analysis. J Psychosom Res. 2016;90:51–6.CrossRef
10.
go back to reference Andrews G, Issakidis C, Sanderson K, Corry J, Lapsley H. Utilising survey data to inform public policy: comparison of the cost-effectiveness of treatment of ten mental disorders. Br J Psychiatry. 2004;184:526–33.CrossRef Andrews G, Issakidis C, Sanderson K, Corry J, Lapsley H. Utilising survey data to inform public policy: comparison of the cost-effectiveness of treatment of ten mental disorders. Br J Psychiatry. 2004;184:526–33.CrossRef
11.
go back to reference Roose SP, Schatzberg AF. The efficacy of antidepressants in the treatment of late-life depression. J Clin Psychopharmacol. 2005;25(Suppl 1):1–7.CrossRef Roose SP, Schatzberg AF. The efficacy of antidepressants in the treatment of late-life depression. J Clin Psychopharmacol. 2005;25(Suppl 1):1–7.CrossRef
12.
go back to reference Whyte EM, Dew MA, Gildengers A, Lenze EJ, Bharucha A, Mulsant BH, Reynolds CF. Time course of response to antidepressants in late-life major depression: therapeutic implications. Drugs Aging. 2004;21:531–54.CrossRef Whyte EM, Dew MA, Gildengers A, Lenze EJ, Bharucha A, Mulsant BH, Reynolds CF. Time course of response to antidepressants in late-life major depression: therapeutic implications. Drugs Aging. 2004;21:531–54.CrossRef
13.
go back to reference Calati R, Signorelli MS, Balestri M, Marsano A, De Ronchi D, Aguglia E, Serritte A. Antidepressants in elderly: Metaregression of double-blind randomized clinical trials. J Affect Disord. 2013;147:1–8.CrossRef Calati R, Signorelli MS, Balestri M, Marsano A, De Ronchi D, Aguglia E, Serritte A. Antidepressants in elderly: Metaregression of double-blind randomized clinical trials. J Affect Disord. 2013;147:1–8.CrossRef
14.
go back to reference Wetherell JL, Petkus AJ, Thorp SR, Stein MB, Chavira DA, Champbell-Sills L, et al. Age differences in treatment response to a collaborative care intervention for anxiety disorders. Br J Psychiatry. 2013;302:65–72.CrossRef Wetherell JL, Petkus AJ, Thorp SR, Stein MB, Chavira DA, Champbell-Sills L, et al. Age differences in treatment response to a collaborative care intervention for anxiety disorders. Br J Psychiatry. 2013;302:65–72.CrossRef
15.
go back to reference Schaakxs R, Comijs HC, Lamers F, Kok RM, Beektman ATF, Penninx BWJH. Associations between age and the course of major depressive disorder: a 2-year longitudinal cohort study. Lancet Psychiatry. 2018;5:581–90.CrossRef Schaakxs R, Comijs HC, Lamers F, Kok RM, Beektman ATF, Penninx BWJH. Associations between age and the course of major depressive disorder: a 2-year longitudinal cohort study. Lancet Psychiatry. 2018;5:581–90.CrossRef
16.
go back to reference Wilhelm K, Mitchell P, Sengoz A, Hickie I, Brodaty H, Boyce B. Treatment resistant depression in an Australian context II: outcome of a series of patients. Aust N Z J Psychiatry. 1994;28:23–33.CrossRef Wilhelm K, Mitchell P, Sengoz A, Hickie I, Brodaty H, Boyce B. Treatment resistant depression in an Australian context II: outcome of a series of patients. Aust N Z J Psychiatry. 1994;28:23–33.CrossRef
17.
go back to reference Mitchell EA, Subramaniam H. Prognosis of depression in old age compared to middle age: a systematic review of comparative studies. Am J Psychiatry. 2005;162:1588–601.CrossRef Mitchell EA, Subramaniam H. Prognosis of depression in old age compared to middle age: a systematic review of comparative studies. Am J Psychiatry. 2005;162:1588–601.CrossRef
18.
go back to reference Schneider G, Heuft G. Medically unexplained and somatoform complaints and disorders in the elderly: a systematic review of the literature. Z Psychosom Med Psychother. 2011;57:115–40.PubMed Schneider G, Heuft G. Medically unexplained and somatoform complaints and disorders in the elderly: a systematic review of the literature. Z Psychosom Med Psychother. 2011;57:115–40.PubMed
19.
go back to reference Oude Voshaar RC. Lack of interventions for anxiety in older people. Br J Psychiatry. 2013;203:8–9.CrossRef Oude Voshaar RC. Lack of interventions for anxiety in older people. Br J Psychiatry. 2013;203:8–9.CrossRef
20.
go back to reference Tedeschini E, Levkovitz Y, Lovieno N, Ameral VE, Nelson JG, Papkostas GI. Efficacy of antidepressant for late-life depression: a meta-analysis and meta-regression of placebo-controlled randomized trials. J Clin Psychiatry. 2011;72:1660–8.CrossRef Tedeschini E, Levkovitz Y, Lovieno N, Ameral VE, Nelson JG, Papkostas GI. Efficacy of antidepressant for late-life depression: a meta-analysis and meta-regression of placebo-controlled randomized trials. J Clin Psychiatry. 2011;72:1660–8.CrossRef
21.
go back to reference Benraad CEM, Kamerman-Celie F, van Munster BC, Oude Voshaar RC, Spijker J, Olde Rikkert MGM. Geriatric characteristics in randomised controlled trials on antidepressant drugs for older adults: a systematic review. Int J Geriatr Psychiatry. 2016;31:990–1003.CrossRef Benraad CEM, Kamerman-Celie F, van Munster BC, Oude Voshaar RC, Spijker J, Olde Rikkert MGM. Geriatric characteristics in randomised controlled trials on antidepressant drugs for older adults: a systematic review. Int J Geriatr Psychiatry. 2016;31:990–1003.CrossRef
22.
go back to reference van der LR, van der Wee NJA, van Veen T, Zitman FG. The generalizability of antidepressant efficacy trials to routine psychiatric out-patient practice. Psychol Med. 2011;41:1353–63.CrossRef van der LR, van der Wee NJA, van Veen T, Zitman FG. The generalizability of antidepressant efficacy trials to routine psychiatric out-patient practice. Psychol Med. 2011;41:1353–63.CrossRef
23.
go back to reference Comijs HC, Van Marwijk HW, Van der Mast RC, et al. The Netherlands study of depression in older persons (NESDO); a prospective cohort study. BMC Res Notes. 2011;4:524.CrossRef Comijs HC, Van Marwijk HW, Van der Mast RC, et al. The Netherlands study of depression in older persons (NESDO); a prospective cohort study. BMC Res Notes. 2011;4:524.CrossRef
24.
go back to reference Comijs HC, Nieuwesteeg J, Kok R, et al. The two-year course of late-life depression; results from the Netherlands study of depression in older persons. BMC Psychiatry. 2015;15(20):015–0401-5. Comijs HC, Nieuwesteeg J, Kok R, et al. The two-year course of late-life depression; results from the Netherlands study of depression in older persons. BMC Psychiatry. 2015;15(20):015–0401-5.
25.
go back to reference de BE, Den Hollander-Gijsman ME, Van Rood YR, et al. Routine outcome monitoring in the Netherlands: practical experiences with a web-based strategy for the assessment of treatment outcome in clinical practice. Clin Psychol Psychother. 2011;18:1–12.CrossRef de BE, Den Hollander-Gijsman ME, Van Rood YR, et al. Routine outcome monitoring in the Netherlands: practical experiences with a web-based strategy for the assessment of treatment outcome in clinical practice. Clin Psychol Psychother. 2011;18:1–12.CrossRef
26.
go back to reference Keet IPM, Nugter AM, Hafkenscheid A, Van den Eede F, Thunnissen MM. ROM: primair een instrument voor de behandeling. Tijdschrift voor Psychiatrie. 2012;54:107–9.PubMed Keet IPM, Nugter AM, Hafkenscheid A, Van den Eede F, Thunnissen MM. ROM: primair een instrument voor de behandeling. Tijdschrift voor Psychiatrie. 2012;54:107–9.PubMed
27.
go back to reference Veerbeek MA, Oude Voshaar RC, Pot AM. Effectiveness and predictors of outcome in routine out-patient mental health care for older adults. Int Psychogeriatr. 2014;29:1565–74.CrossRef Veerbeek MA, Oude Voshaar RC, Pot AM. Effectiveness and predictors of outcome in routine out-patient mental health care for older adults. Int Psychogeriatr. 2014;29:1565–74.CrossRef
28.
go back to reference Hafkenscheid A, van Os J. ROM measurements in mental health c are: users need to be aware of the problems and pitfalls. Tijdschr Psychiatr. 2016;58:388–96.PubMed Hafkenscheid A, van Os J. ROM measurements in mental health c are: users need to be aware of the problems and pitfalls. Tijdschr Psychiatr. 2016;58:388–96.PubMed
29.
go back to reference van Vliet IM, Leroy H, van Megen HJGM, M.I.N.I Plus, Internationaal Neuropsychiatrisch Interview, Nederlandse versie 5.0.0., 2000. van Vliet IM, Leroy H, van Megen HJGM, M.I.N.I Plus, Internationaal Neuropsychiatrisch Interview, Nederlandse versie 5.0.0., 2000.
30.
go back to reference Sheehan DV, Lecrubrier Y. MINI Plus, international neuropsychiatric interview. Tampa: University of South Florida; 1998. Sheehan DV, Lecrubrier Y. MINI Plus, international neuropsychiatric interview. Tampa: University of South Florida; 1998.
31.
go back to reference Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal cognitive assessment (MoCA): a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53:695–9.CrossRef Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal cognitive assessment (MoCA): a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53:695–9.CrossRef
32.
go back to reference Rush AJ, Gullion CM, Basco MR, et al. The inventory of depressive symptomatology (IDS): psychometric properties. Psychol Med. 1996;26:477–86.CrossRef Rush AJ, Gullion CM, Basco MR, et al. The inventory of depressive symptomatology (IDS): psychometric properties. Psychol Med. 1996;26:477–86.CrossRef
33.
go back to reference Pachana NA, Byrne GJ, Siddle H, et al. Development and validation of the geriatric anxiety inventory. Int Psychogeriatr. 2007;19:103–14.CrossRef Pachana NA, Byrne GJ, Siddle H, et al. Development and validation of the geriatric anxiety inventory. Int Psychogeriatr. 2007;19:103–14.CrossRef
34.
go back to reference Speckens A, Hemert van A, Spinhoven J, et al. A validation study of the whitely index, illness attitude scale and somatosensory amplification scale. J Psychosom Res. 1996;40:95–104.CrossRef Speckens A, Hemert van A, Spinhoven J, et al. A validation study of the whitely index, illness attitude scale and somatosensory amplification scale. J Psychosom Res. 1996;40:95–104.CrossRef
35.
go back to reference Speckens A, Hemert van A, Spinhoven P, et al. The diagnostic and prognostic significance of the whitely index, the illness attitude scale and Somatofosensory Amplication scale. Psychol Med. 1996;26:1085–90.CrossRef Speckens A, Hemert van A, Spinhoven P, et al. The diagnostic and prognostic significance of the whitely index, the illness attitude scale and Somatofosensory Amplication scale. Psychol Med. 1996;26:1085–90.CrossRef
36.
go back to reference Babor TF, Kranzler HR, Lauerman RJ. Early detection of harmful alcohol consumption: comparison of clinical, laboratory, and self-report screening procedures. Addict Behav. 1989;14:139–57.CrossRef Babor TF, Kranzler HR, Lauerman RJ. Early detection of harmful alcohol consumption: comparison of clinical, laboratory, and self-report screening procedures. Addict Behav. 1989;14:139–57.CrossRef
38.
go back to reference Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–98.CrossRef Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–98.CrossRef
39.
go back to reference Pilowsky I. Dimensions of hypochondriasis. Br J Psychiatry. 1967;113:39–43.CrossRef Pilowsky I. Dimensions of hypochondriasis. Br J Psychiatry. 1967;113:39–43.CrossRef
40.
go back to reference Chambless DL, Caputo CG, Jasin SE, et al. The mobility inventory for agoraphobia. Behav Res Ther. 1985;23:35–44.CrossRef Chambless DL, Caputo CG, Jasin SE, et al. The mobility inventory for agoraphobia. Behav Res Ther. 1985;23:35–44.CrossRef
41.
go back to reference Meyer TJ, Miller ML, Metzger RL, et al. Development and validation of the Penn State worry questionnaire. Behav Res Ther. 1990;28:487–95.CrossRef Meyer TJ, Miller ML, Metzger RL, et al. Development and validation of the Penn State worry questionnaire. Behav Res Ther. 1990;28:487–95.CrossRef
42.
go back to reference Leibowitz MR. Social Phobia. Mod Prob Pharmacopsychiatry. 1987;22:141–73.CrossRef Leibowitz MR. Social Phobia. Mod Prob Pharmacopsychiatry. 1987;22:141–73.CrossRef
43.
go back to reference Chwastiak LA, Von Korff M. Disability in depression and back pain: evaluation of the World Health Organization disability assessment schedule (WHO DAS II) in a primary care setting. J Clin Epidemiol. 2003;56:507–14.CrossRef Chwastiak LA, Von Korff M. Disability in depression and back pain: evaluation of the World Health Organization disability assessment schedule (WHO DAS II) in a primary care setting. J Clin Epidemiol. 2003;56:507–14.CrossRef
44.
go back to reference Kriegsman DM, Penninx BW, Van Eijk JT, et al. Self-reports and general practitioner information on the presence of chronic diseases in community dwelling elderly. A study on the accuracy of patients' self-reports and on determinants of inaccuracy. J Clin Epidemiol. 1996;49:1407–17.CrossRef Kriegsman DM, Penninx BW, Van Eijk JT, et al. Self-reports and general practitioner information on the presence of chronic diseases in community dwelling elderly. A study on the accuracy of patients' self-reports and on determinants of inaccuracy. J Clin Epidemiol. 1996;49:1407–17.CrossRef
45.
go back to reference Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol. 2001;56A:146–56.CrossRef Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol. 2001;56A:146–56.CrossRef
46.
go back to reference Gobbens RJJ, van Assen MALM, Luijkx KG, et al. The Tilburg frailty Indicator: psychometric properties. JAMDA. 2010;11:344–55.PubMed Gobbens RJJ, van Assen MALM, Luijkx KG, et al. The Tilburg frailty Indicator: psychometric properties. JAMDA. 2010;11:344–55.PubMed
47.
go back to reference Gobbens RJ, Van Assen MA, Luijkx KG, et al. The predictive validity of the Tilburg frailty Indicator: disability, health care utilization, and quality of life in a population at risk. Gerontologist. 2012;52:619–31.CrossRef Gobbens RJ, Van Assen MA, Luijkx KG, et al. The predictive validity of the Tilburg frailty Indicator: disability, health care utilization, and quality of life in a population at risk. Gerontologist. 2012;52:619–31.CrossRef
48.
go back to reference Grundy S, Brewer HB, Cleeman JI, Smith SC. Lenfant C NHLBI/AHA conference proceedings: definition of metabolic syndrome. Circulation. 2004;109:433–8.CrossRef Grundy S, Brewer HB, Cleeman JI, Smith SC. Lenfant C NHLBI/AHA conference proceedings: definition of metabolic syndrome. Circulation. 2004;109:433–8.CrossRef
49.
go back to reference Simm A. Protein glycation during aging and in cardiovascular disease. J Proteome. 2013; in press. Simm A. Protein glycation during aging and in cardiovascular disease. J Proteome. 2013; in press.
50.
go back to reference Smit AJ, Gerrits EG. Skin autofluorescence as a measure of advanced glycation endproduct deposition: a novel risk marker in chronic kidney disease. Curr Opin Nephrol Hypertens. 2010;19:527–33.CrossRef Smit AJ, Gerrits EG. Skin autofluorescence as a measure of advanced glycation endproduct deposition: a novel risk marker in chronic kidney disease. Curr Opin Nephrol Hypertens. 2010;19:527–33.CrossRef
51.
go back to reference Zuidersma M, Izaks GJ, Naarding P, Comijs HC, Oude Voshaar RC. Vascular burden and cognitive function in late-life depression. Am J Geriatr Psychiatry. 2015;23:514–24.CrossRef Zuidersma M, Izaks GJ, Naarding P, Comijs HC, Oude Voshaar RC. Vascular burden and cognitive function in late-life depression. Am J Geriatr Psychiatry. 2015;23:514–24.CrossRef
52.
go back to reference Stroop JR. Studies of interference in serial verbal reactions. J Exp Psychol. 1935;18:643–62.CrossRef Stroop JR. Studies of interference in serial verbal reactions. J Exp Psychol. 1935;18:643–62.CrossRef
53.
go back to reference Wechsler D. The measurement and appraisal of adult intelligence. 4th ed. Baltimore: Williams & Wilkins; 1958.CrossRef Wechsler D. The measurement and appraisal of adult intelligence. 4th ed. Baltimore: Williams & Wilkins; 1958.CrossRef
54.
go back to reference van der Elst W, Van Boxtel MP, Van Breukelen GJ, Jolles J. Rey’s verbal learning test: normative data for 1855 healthy participants aged 24-81 years and the influence of age, sex, education, and mode of presentation. J Int Neuropsychol Soc. 2005;11:290–302.CrossRef van der Elst W, Van Boxtel MP, Van Breukelen GJ, Jolles J. Rey’s verbal learning test: normative data for 1855 healthy participants aged 24-81 years and the influence of age, sex, education, and mode of presentation. J Int Neuropsychol Soc. 2005;11:290–302.CrossRef
55.
go back to reference Rey A. L’examen clinique en psychologie. Paris: Presses Universitaire de France; 1964. Rey A. L’examen clinique en psychologie. Paris: Presses Universitaire de France; 1964.
56.
go back to reference Costa PT, McCrae RR. Domains and facets: hierarchical personality assessment using the revised NEO personality inventory. J Pers Assess. 1995;64:21–50.CrossRef Costa PT, McCrae RR. Domains and facets: hierarchical personality assessment using the revised NEO personality inventory. J Pers Assess. 1995;64:21–50.CrossRef
57.
go back to reference de GR, Bijl RV, Ten Have M, et al. Pathways to comorbidity: the transition of pure mood, anxiety and substance use disorders into comorbid conditions in a longitudinal population-based study. J Affect Disord. 2004;82:461–7.CrossRef de GR, Bijl RV, Ten Have M, et al. Pathways to comorbidity: the transition of pure mood, anxiety and substance use disorders into comorbid conditions in a longitudinal population-based study. J Affect Disord. 2004;82:461–7.CrossRef
58.
go back to reference Brugha T, Bebbington P, Tennant C, et al. The list of threatening experiences: a subset of 12 life event categories with considerable long-term contextual threat. Psychol Med. 1985;15:189–94.CrossRef Brugha T, Bebbington P, Tennant C, et al. The list of threatening experiences: a subset of 12 life event categories with considerable long-term contextual threat. Psychol Med. 1985;15:189–94.CrossRef
59.
go back to reference Cohen S, Doyle WJ, Skoner DP, Rabin BS, Gwaltney JM. Social ties and susceptibility to the common cold. JAMA. 1997;277:1940–4.CrossRef Cohen S, Doyle WJ, Skoner DP, Rabin BS, Gwaltney JM. Social ties and susceptibility to the common cold. JAMA. 1997;277:1940–4.CrossRef
60.
go back to reference de Jong Gierveld J, Kamphuis FH. The development of a rasch type loneliness scale. Appl Pschol Meas. 1985;9:289–99.CrossRef de Jong Gierveld J, Kamphuis FH. The development of a rasch type loneliness scale. Appl Pschol Meas. 1985;9:289–99.CrossRef
61.
go back to reference Levine DW, Kaplan RM, Kripke DF, et al. Factor structure and measurement invariance of the Women's Health Initiative insomnia rating scale. Psychol Assess. 2003;15:123–36.CrossRef Levine DW, Kaplan RM, Kripke DF, et al. Factor structure and measurement invariance of the Women's Health Initiative insomnia rating scale. Psychol Assess. 2003;15:123–36.CrossRef
62.
go back to reference Craig CL, Marshall AL, Sjostrom M, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35:1381–95.CrossRef Craig CL, Marshall AL, Sjostrom M, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35:1381–95.CrossRef
63.
go back to reference Schuurmans H, Steverink N, Frieswijk N, et al. How to measure self-management abilities in older people by self-report. The development of the SMAS-30. Qual Life Res. 2005;14:2215–28.CrossRef Schuurmans H, Steverink N, Frieswijk N, et al. How to measure self-management abilities in older people by self-report. The development of the SMAS-30. Qual Life Res. 2005;14:2215–28.CrossRef
64.
go back to reference Twisk JWR. Applied longitudinal data analysis for epidemiology. A practical guide. Cambridge: Cambridge University Press; 2003. Twisk JWR. Applied longitudinal data analysis for epidemiology. A practical guide. Cambridge: Cambridge University Press; 2003.
65.
go back to reference STATA, data analysis and statistical software, version 15. STATA, data analysis and statistical software, version 15.
66.
go back to reference Converting among effect sizes. In: Borenstein M, Hedges LV, Higgins JPT, Rothstein HR, editors, Introduction to Meta-Analysis. Chichester, West Sussex, UK: Wiley 2009, chapter 7. Converting among effect sizes. In: Borenstein M, Hedges LV, Higgins JPT, Rothstein HR, editors, Introduction to Meta-Analysis. Chichester, West Sussex, UK: Wiley 2009, chapter 7.
67.
go back to reference Huisman M, Poppelaars J, van der Horst M, et al. Cohort profile: the longitudinal aging study Amsterdam. Int J Epidemiol. 2011;40:868–76.CrossRef Huisman M, Poppelaars J, van der Horst M, et al. Cohort profile: the longitudinal aging study Amsterdam. Int J Epidemiol. 2011;40:868–76.CrossRef
68.
go back to reference United Nations, Department of Economic and Social Affairs, Population Division (2017). World population prospects: the 2017 revision, key findings and advance tables. Working paper no. ESA/P/WP/248. United Nations, Department of Economic and Social Affairs, Population Division (2017). World population prospects: the 2017 revision, key findings and advance tables. Working paper no. ESA/P/WP/248.
69.
go back to reference Collard RM, Arts MH, Schene AH, Naarding P, Oude Voshaar RC, Comijs HC. The impact of frailty on depressive disorder in later life: findings from the Netherlands study of depression in older persons. Eur Psychiatry. 2017;43:66–72.CrossRef Collard RM, Arts MH, Schene AH, Naarding P, Oude Voshaar RC, Comijs HC. The impact of frailty on depressive disorder in later life: findings from the Netherlands study of depression in older persons. Eur Psychiatry. 2017;43:66–72.CrossRef
70.
go back to reference Marijnissen RM, Vogelzangs N, Mulder ME, van den Brink RHS, Comijs HC, Oude Voshaar RC. Metabolic dysregulation and late-life depression; a prospective study. Psychol Med. 2017;47:1041–52.CrossRef Marijnissen RM, Vogelzangs N, Mulder ME, van den Brink RHS, Comijs HC, Oude Voshaar RC. Metabolic dysregulation and late-life depression; a prospective study. Psychol Med. 2017;47:1041–52.CrossRef
71.
go back to reference Alexopoulos GS, Raue PJ, Kiosses DN, Mackin RS, Kanellopoulos D, McCulloch C, Arean PA. Problem-solving therapy and supportive therapy in older adults with major depression and executive dysfunction: effect on disability. Arch Gen Psychiatry. 2011;68:33–41.CrossRef Alexopoulos GS, Raue PJ, Kiosses DN, Mackin RS, Kanellopoulos D, McCulloch C, Arean PA. Problem-solving therapy and supportive therapy in older adults with major depression and executive dysfunction: effect on disability. Arch Gen Psychiatry. 2011;68:33–41.CrossRef
72.
go back to reference Taylor WE, Aizenstein HJ, Alexopoulos GS. The vascular depression hypothesis: mechanisms linking vascular disease with depression. Mol Psychiatry. 2013;18:963–74.CrossRef Taylor WE, Aizenstein HJ, Alexopoulos GS. The vascular depression hypothesis: mechanisms linking vascular disease with depression. Mol Psychiatry. 2013;18:963–74.CrossRef
73.
go back to reference Arts MHL, Benraad CEM, Hanssen D, Hilderink P, de Jonge L, Naarding P, Lucassen P, Oude Voshaar RC. Frailty and somatic comorbidity in older patients with medically unexplained symptoms. J Am Med Dir Assoc. 2019; in press. Arts MHL, Benraad CEM, Hanssen D, Hilderink P, de Jonge L, Naarding P, Lucassen P, Oude Voshaar RC. Frailty and somatic comorbidity in older patients with medically unexplained symptoms. J Am Med Dir Assoc. 2019; in press.
74.
go back to reference Delespaul PAEG. Routine outcome measurement in the Netherlands – a focus on benchmarking. Int Rev Psychiatry. 2015;27:320–8.CrossRef Delespaul PAEG. Routine outcome measurement in the Netherlands – a focus on benchmarking. Int Rev Psychiatry. 2015;27:320–8.CrossRef
75.
go back to reference Van Alphen SP, van Dijk SD, Videlder AC, Rossi G, Dierckx E, Bouckaert F, Oude Voshaar RC. Personality disorders in older adults: emerging research issues. Curr Psychiatry Rep. 2015;17:538.CrossRef Van Alphen SP, van Dijk SD, Videlder AC, Rossi G, Dierckx E, Bouckaert F, Oude Voshaar RC. Personality disorders in older adults: emerging research issues. Curr Psychiatry Rep. 2015;17:538.CrossRef
76.
go back to reference Mohlman J, Bryant C, Lenze EJ, Stanley MA, Gum A, Flint A, Beekman AT, Wetherell JL, Thorp SR, Craske MG. Improving recognition of late life anxiety disorders in diagnostic and statistical manual of mental disorders, fifth edition: observations and recommendations of the advisory committee to the lifespan disorders work group. Int J Geriatr Psychiatry. 2012;27:549–56.CrossRef Mohlman J, Bryant C, Lenze EJ, Stanley MA, Gum A, Flint A, Beekman AT, Wetherell JL, Thorp SR, Craske MG. Improving recognition of late life anxiety disorders in diagnostic and statistical manual of mental disorders, fifth edition: observations and recommendations of the advisory committee to the lifespan disorders work group. Int J Geriatr Psychiatry. 2012;27:549–56.CrossRef
77.
go back to reference Kim DH, Pieper CF, Ahmed A, Colon-Emeric CS. Use and interpretation of propensity scores in aging research: a guide for clinical researchers. J Am Geriatr Soc. 2016;64:2065–73.CrossRef Kim DH, Pieper CF, Ahmed A, Colon-Emeric CS. Use and interpretation of propensity scores in aging research: a guide for clinical researchers. J Am Geriatr Soc. 2016;64:2065–73.CrossRef
Metadata
Title
Study design of the Routine Outcome Monitoring for Geriatric Psychiatry & Science (ROM-GPS) project; a cohort study of older patients with affective disorders referred for specialised geriatric mental health care
Authors
Richard C. Oude Voshaar
Ton D. F. Dhondt
Mario Fluiter
Paul Naarding
Sanne Wassink
Maureen M. J. Smeets
Loeki P. R. M. Pelzers
Astrid Lugtenburg
Martine Veenstra
Radboud M. Marijnissen
Gert-Jan Hendriks
Lia A. Verlinde
Robert A. Schoevers
Rob H. S. van den Brink
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Psychiatry / Issue 1/2019
Electronic ISSN: 1471-244X
DOI
https://doi.org/10.1186/s12888-019-2176-6

Other articles of this Issue 1/2019

BMC Psychiatry 1/2019 Go to the issue